Pacferatam

Pacferatam

cefoperazone + sulbactam

Manufacturer:

Pacific Pharma

Distributor:

AA Medical
Concise Prescribing Info
Contents
Cefoperazone Na, sulbactam Na
Indications/Uses
Acute & chronic bronchitis, bronchiectasia, secondary infection of chronic resp diseases, pneumonia, pulmonary pyopoiesis, empyema, laryngopharyngitis, tonsillitis; pyelonephritis, cystitis; cholecystitis, cholangitis, hepatopostema, peritonitis; uterine appendages, pelvic, parametrium & Bartholin gland inflammation; intrauterine infection; sepsis; endocarditis; superficial secondary infection (trauma, surgical wound).
Dosage/Direction for Use
Adult 2-4 g IV daily in 2 divided doses 12 hrly. May be increased to 8 g/day if necessary. Childn 40-80 mg/kg IV daily in 2-4 divided doses. May be increased to 160 mg/kg.
Contraindications
Hypersensitivity to cephem class & penicillins. Severe renal & hepatic failure.
Special Precautions
May permit overgrowth of Clostridium difficile. Hepatic disease, severe biliary obstruction, renal dysfunction. Monitor prothrombin time in patients w/ poor diet, malabsorption states (eg, cystic fibrosis), prolonged IV alimentation regimens. Not for hypodermic or IM inj. Monitor serum concentrations. Pregnancy & lactation. Elderly.
Adverse Reactions
Rash, urticaria, erythema, pruritus, fever; hemolytic anemia, panhematopenia, granulocytopenia, erythropenia, eosinophilia, thrombocytopenia, hemolytic anemia; elevation of AST, ALT, ALP & bilirubin; GI disturbances, convulsion.
Drug Interactions
Alcohol. Other cephem drugs, diuretics eg, furosemide.
MIMS Class
Cephalosporins
ATC Classification
J01DD62 - cefoperazone and beta-lactamase inhibitor ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections.
Presentation/Packing
Form
Pacferatam powd for inj
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in